To build on the results of this study, future research will benefit from examining the heritability of variants in DDR genes and HOXB13 to determine whether first-degree relatives with the same genotype truly have an increased susceptibility to developing cancer, and whether carriers are at an increased risk of developing malignancies other than prostate cancer. This evidence concerns the gene HOXB13 and cancer.